Copyright
©The Author(s) 2015.
World J Gastroenterol. Jan 14, 2015; 21(2): 475-483
Published online Jan 14, 2015. doi: 10.3748/wjg.v21.i2.475
Published online Jan 14, 2015. doi: 10.3748/wjg.v21.i2.475
Figure 4 Epithelial-mesenchymal transition-like phenotype and upregulation of related markers in hepatocellular carcinoma cells with chemokine ligand 20.
A: Morphologic changes in Hep3B and Huh7 cells after treatment with chemokine ligand 20 (CCL20) for 48 h (most cells exhibited an elongated, spindle-shape mesenchymal morphology with treatment); B: Immunocytochemistry for phosphorylated AKT (p-AKT) and β-catenin in Hep3B and Huh7 cells after treatment with CCL20 for 48 h (magnification × 200).
-
Citation: Hou KZ, Fu ZQ, Gong H. Chemokine ligand 20 enhances progression of hepatocellular carcinoma
via epithelial-mesenchymal transition. World J Gastroenterol 2015; 21(2): 475-483 - URL: https://www.wjgnet.com/1007-9327/full/v21/i2/475.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i2.475